Company intelligence / Profile preview

Mint Capital

Ownership: Private
Development stage: Other

Overview

Mint Capital appears to be an investment firm rather than a life sciences operating company. Public profiles describe it as a Scandinavian private equity fund that provides growth capital to early-stage companies, and historical disclosures show a Mint Capital Limited participating in structured financing transactions with healthcare issuers such as Hemogenyx Pharmaceuticals. Based on currently available information, Mint Capital itself does not appear to develop therapeutic products, run a drug pipeline, or operate as a biotech, pharma, CRO, or CDMO. It is therefore best classified as a financial investor with some exposure to healthcare-related investments rather than a healthcare company.

Industry: Investors

Beyond the preview

Go deeper on Mint Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mint Capital.

Explore the full profile